Elypta (private company)

See something wrong or missing? Let us know
Offices:
Gothenburg, Stockholm
Business model:
B2B
Investors:
we tracked 5 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 2 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Elypta is a molecular diagnostic company focused on preventing cancer mortality by developing a liquid biopsy platform for detection and monitoring of the disease. The approach is based on measurement of 20 biomarkers and use of machine learning algorithms to generate a score against cancer-type specific signatures.

Companies with similar profile to Elypta:

CompanyCriteria
Sweden AMRA
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Oncomatryx
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Monocl
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark CysBio
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Athera
46%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden BoneSupport
46%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden NuvoAir
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 5M - 10M USD
Sweden Trialbee
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 5M - 10M USD
Spain Leuko
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Nina Capital
  • Minim one investor from outside Scandinavia: Yes
Sweden Gesynta Pharma
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 5M - 10M USD
Sweden OxThera
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Minim one investor from outside Scandinavia: Yes
Sweden Glionova
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 5M - 10M USD
Finland Combinostics
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 5M - 10M USD
Sweden Aprea Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Finland TILT Biotherapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Finland Optomed
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Sanifit Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Burt
44%
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Mantex
44%
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark NMD Pharma
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes